• Profile
Close

Early risk of readmission following hospitalization for reversible cerebral vasoconstriction syndrome

Neurology® Jun 17, 2021

Garg A, Starr M, Rocha M, et al. - Researchers herein assessed 90-day readmissions following an inpatient admission for reversible cerebral vasoconstriction syndrome (RCVS). Survival analysis was conducted, and multivariable Cox proportional hazards regression was utilized to determine the factors associated with readmission. One hundred sixty-four (14.2%) of the 1,157 patients admitted to the hospital due to RCVS during the study period (mean ± SD age 48.6 ± 16.1 years, women 76.4%) had nonelective readmission within 90 days of discharge. Acute cerebrovascular events, continued or recurrent symptoms of RCVS, infections, and headache were the most common reasons for readmissions. Diabetes, history of tobacco use, opioid use, and longer length of index hospitalization were all found to be independent predictors of 90-day readmission. Within 90 days following discharge, over 14% of patients with RCVS are readmitted, with a large number of these readmissions due to ongoing/recurrent symptoms or neurologic sequelae of RCVS. Given the risk of early recurrence/worsening of symptoms in these patients, an early postdischarge follow-up plan may need to be incorporated into their care.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay